Thursday, 16 August 2018
Latest news
Main » CBD carries no addiction risks, World Health Organization confirms

CBD carries no addiction risks, World Health Organization confirms

16 December 2017

On Dec. 13, the World Health Organization (WHO) announced that a cannabis compound called cannabidiol (CBD) "could have therapeutic value" for epilepsy-related seizures.

"There is increased interest from Member States in the use of cannabis for medical indications including for palliative care".

According to Newsweek, WHO is not yet recommending CBD use but feels that "cannabidiol should not be scheduled for global control on the basis of current evidence, and that a fuller review will be carried out next year, when other cannabinoids are discussed". "Current evidence also shows that cannabidiol is not likely to be abused or create dependence as for other cannabinoids (such as Tetra Hydro Cannabinol (THC), for instance)".

CBD gift guide
CBD carries no addiction risks, World Health Organization confirms

"The ECDD therefore concluded that current information does not justify scheduling of cannabidiol" as a unsafe drug, the announcement reads.

The health organisation is planning to carry out a fuller review of CBD next year when cannabis-related substances will be assessed further. They have also recommended medical marijuana to be removed from the Scheduled substances lists around the world. "CBD should never be a scheduled drug", Elizalde told Westword.

While the study, which used human and animal subjects, concluded the CBD could help with seizures and isn't likely to lead to addiction, World Health Organization has not commented on CBD's usefulness in treating other diseases and disorders, and didn't go as far to say that marijuana doesn't have any negative side effects.

More news: What the NLRB's New Joint Employer Decision Means for the Labor Market

In fact, the natural component is known to help in treating epilepsy and several other medical conditions. There's even a pure CBD product (Epidiolex®) now in phase III trials. "There is unsanctioned medical use of CBD based products with oils, supplements, gums, and high concentration extracts available online for the treatment of many ailments", the study noted.

"CBD is generally well tolerated with a good safety profile", the authors of the report wrote.

Scientists conducted a small trial of people with psychosis and found patients treated with CBD had lower levels of psychotic symptoms than those who received a placebo.

More news: Schiphol airport: Man with a knife shot by police

"To date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD", the study pointed out.

Because federal law makes it a crime to have marijuana and CBD, researchers must pass strict government scrutiny just to study its usefulness. In its announcement about CBD, the health organization did, however, recommend the most stringent level of worldwide control for the synthetic opioid carfentanil, a drug originally created to restrain and capture large animals like giraffes in emergency situations in zoos, that is now being abused by humans.

More news: SpaceX debut of recycled rocket and new launch pad

CBD carries no addiction risks, World Health Organization confirms